MGNX earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -3.91. Updated 2026-07-23.
MacroGenics (MGNX) Research Hub
MacroGenics (MGNX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.19 USD (-2.67%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.91, market cap 0.28B. This hub links to the full technical, earnings and options research available for MGNX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.19 USD (-2.67%) |
| 52-week range | 1.93 USD – 5.08 USD |
| Trend regime | Range |
| 14-day RSI | 23.2 (Oversold) |
| Trailing P/E | -3.91 |
| Market cap | 0.28B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for MGNX
Covered Call on MGNX: how it works, illustrative setup around the real 2.19 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MGNX: how it works, illustrative setup around the real 2.19 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MGNX: how it works, illustrative setup around the real 2.19 USD price, max profit/loss, breakeven and when to use it. Educational.
MGNX technical analysis: range, last 2.19 USD, RSI 23.2, 52w range 1.93 USD–5.08 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MGNX in?
MacroGenics (MGNX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MGNX in an uptrend or downtrend?
As of 2026-10-26, MGNX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MGNX's trailing P/E ratio?
MGNX's trailing P/E is -3.91, with a market cap of 0.28B. See the earnings research page for full valuation detail.
When does MGNX next report earnings?
MGNX is next scheduled to report earnings on 2026-08-13.